NORETHIN 1 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norethin 1, and when can generic versions of Norethin 1 launch?
Norethin 1 is a drug marketed by Watson Pharms Teva, Watson Labs, and Heritage Pharma. and is included in four NDAs.
The generic ingredient in NORETHIN 1 is mestranol; norethindrone. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORETHIN 1?
- What are the global sales for NORETHIN 1?
- What is Average Wholesale Price for NORETHIN 1?
Summary for NORETHIN 1
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| DailyMed Link: | NORETHIN 1 at DailyMed |
US Patents and Regulatory Information for NORETHIN 1
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Pharms Teva | NORETHIN 1/35E-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 071480-001 | Apr 12, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Heritage Pharma | NORETHIN 1/50M-28 | mestranol; norethindrone | TABLET;ORAL-28 | 071540-001 | Apr 12, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | NORETHIN 1/35E-28 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 071481-001 | Apr 12, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
